Publication Information

{'id': 'https://openalex.org/W1968568016', 'doi': 'https://doi.org/10.1517/13543784.16.7.1111', 'title': 'Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma', 'display_name': 'Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma', 'publication_year': 2007, 'publication_date': '2007-06-26', 'ids': {'openalex': 'https://openalex.org/W1968568016', 'doi': 'https://doi.org/10.1517/13543784.16.7.1111', 'mag': '1968568016', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/17594194'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1517/13543784.16.7.1111', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S131064935', 'display_name': 'Expert Opinion on Investigational Drugs', 'issn_l': '1354-3784', 'issn': ['1354-3784', '1744-7658'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'review', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5030460763', 'display_name': 'Madeleine Duvic', 'orcid': 'https://orcid.org/0000-0002-8971-4565'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Madeleine Duvic', 'raw_affiliation_strings': ['University of Texas MD Anderson Cancer Center, Department of Dermatology, 1515 Holcombe Boulevard, Houston, TX 77030, USA. [email protected]'], 'affiliations': [{'raw_affiliation_string': 'University of Texas MD Anderson Cancer Center, Department of Dermatology, 1515 Holcombe Boulevard, Houston, TX 77030, USA. [email protected]', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5054880388', 'display_name': 'Jenny Vu', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Jenny Vu', 'raw_affiliation_strings': ['General Oncology'], 'affiliations': [{'raw_affiliation_string': 'General Oncology', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 2.911, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 317, 'citation_normalized_percentile': {'value': 0.999684, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 99, 'max': 100}, 'biblio': {'volume': '16', 'issue': '7', 'first_page': '1111', 'last_page': '1120'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11736', 'display_name': 'Histone Deacetylase Inhibitors Research', 'score': 0.9967, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11736', 'display_name': 'Histone Deacetylase Inhibitors Research', 'score': 0.9967, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12159', 'display_name': 'T-cell and Retrovirus Studies', 'score': 0.9966, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11811', 'display_name': 'Cutaneous lymphoproliferative disorders research', 'score': 0.9912, 'subfield': {'id': 'https://openalex.org/subfields/2708', 'display_name': 'Dermatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/vorinostat', 'display_name': 'Vorinostat', 'score': 0.97963864}, {'id': 'https://openalex.org/keywords/histone-deacetylase-inhibitor', 'display_name': 'Histone deacetylase inhibitor', 'score': 0.6810976}, {'id': 'https://openalex.org/keywords/cutaneous-t-cell-lymphoma', 'display_name': 'Cutaneous T-cell lymphoma', 'score': 0.63167816}], 'concepts': [{'id': 'https://openalex.org/C2776262904', 'wikidata': 'https://www.wikidata.org/wiki/Q905901', 'display_name': 'Vorinostat', 'level': 5, 'score': 0.97963864}, {'id': 'https://openalex.org/C2776202225', 'wikidata': 'https://www.wikidata.org/wiki/Q3569101', 'display_name': 'Histone deacetylase inhibitor', 'level': 5, 'score': 0.6810976}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.6699053}, {'id': 'https://openalex.org/C2776780870', 'wikidata': 'https://www.wikidata.org/wiki/Q5196687', 'display_name': 'Cutaneous T-cell lymphoma', 'level': 4, 'score': 0.63167816}, {'id': 'https://openalex.org/C2778305200', 'wikidata': 'https://www.wikidata.org/wiki/Q174378', 'display_name': 'Histone deacetylase', 'level': 4, 'score': 0.60093576}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.5018213}, {'id': 'https://openalex.org/C2779338263', 'wikidata': 'https://www.wikidata.org/wiki/Q208414', 'display_name': 'Lymphoma', 'level': 2, 'score': 0.46350923}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.44770175}, {'id': 'https://openalex.org/C64927066', 'wikidata': 'https://www.wikidata.org/wiki/Q36293', 'display_name': 'Histone', 'level': 3, 'score': 0.28402996}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.21535832}, {'id': 'https://openalex.org/C2777756187', 'wikidata': 'https://www.wikidata.org/wiki/Q1891209', 'display_name': 'Mycosis fungoides', 'level': 3, 'score': 0.20565662}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.1484747}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D015507', 'descriptor_name': 'Drugs, Investigational', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D056572', 'descriptor_name': 'Histone Deacetylase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D006877', 'descriptor_name': 'Hydroxamic Acids', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D016410', 'descriptor_name': 'Lymphoma, T-Cell, Cutaneous', 'qualifier_ui': 'Q000175', 'qualifier_name': 'diagnosis', 'is_major_topic': True}, {'descriptor_ui': 'D016410', 'descriptor_name': 'Lymphoma, T-Cell, Cutaneous', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000284', 'descriptor_name': 'Administration, Oral', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017321', 'descriptor_name': 'Clinical Trials, Phase I as Topic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017322', 'descriptor_name': 'Clinical Trials, Phase II as Topic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004195', 'descriptor_name': 'Disease Models, Animal', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004305', 'descriptor_name': 'Dose-Response Relationship, Drug', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004334', 'descriptor_name': 'Drug Administration Schedule', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006877', 'descriptor_name': 'Hydroxamic Acids', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D006877', 'descriptor_name': 'Hydroxamic Acids', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007150', 'descriptor_name': 'Immunohistochemistry', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016410', 'descriptor_name': 'Lymphoma, T-Cell, Cutaneous', 'qualifier_ui': 'Q000401', 'qualifier_name': 'mortality', 'is_major_topic': False}, {'descriptor_ui': 'D016410', 'descriptor_name': 'Lymphoma, T-Cell, Cutaneous', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020714', 'descriptor_name': 'Maximum Tolerated Dose', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051379', 'descriptor_name': 'Mice', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008819', 'descriptor_name': 'Mice, Nude', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009367', 'descriptor_name': 'Neoplasm Staging', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011379', 'descriptor_name': 'Prognosis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018570', 'descriptor_name': 'Risk Assessment', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016019', 'descriptor_name': 'Survival Analysis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077337', 'descriptor_name': 'Vorinostat', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1517/13543784.16.7.1111', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S131064935', 'display_name': 'Expert Opinion on Investigational Drugs', 'issn_l': '1354-3784', 'issn': ['1354-3784', '1744-7658'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/17594194', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.83, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 61, 'referenced_works': ['https://openalex.org/W1739537573', 'https://openalex.org/W1812576394', 'https://openalex.org/W1967018540', 'https://openalex.org/W1969496794', 'https://openalex.org/W1973899902', 'https://openalex.org/W1978664410', 'https://openalex.org/W1982619775', 'https://openalex.org/W1983101833', 'https://openalex.org/W1985198089', 'https://openalex.org/W1990801507', 'https://openalex.org/W1998977801', 'https://openalex.org/W2003907016', 'https://openalex.org/W2004440602', 'https://openalex.org/W2013715448', 'https://openalex.org/W2022093757', 'https://openalex.org/W2022285476', 'https://openalex.org/W2027121379', 'https://openalex.org/W2030822086', 'https://openalex.org/W2034420402', 'https://openalex.org/W2037975991', 'https://openalex.org/W2052453190', 'https://openalex.org/W2054821802', 'https://openalex.org/W2059238397', 'https://openalex.org/W2061352751', 'https://openalex.org/W2062222985', 'https://openalex.org/W2064608106', 'https://openalex.org/W2066052727', 'https://openalex.org/W2070433411', 'https://openalex.org/W2071115015', 'https://openalex.org/W2072936571', 'https://openalex.org/W2076475884', 'https://openalex.org/W2086554451', 'https://openalex.org/W2095083637', 'https://openalex.org/W2102169774', 'https://openalex.org/W2103721535', 'https://openalex.org/W2107040737', 'https://openalex.org/W2107733280', 'https://openalex.org/W2112351720', 'https://openalex.org/W2113144329', 'https://openalex.org/W2115782311', 'https://openalex.org/W2123245958', 'https://openalex.org/W2123927456', 'https://openalex.org/W2135619784', 'https://openalex.org/W2135879713', 'https://openalex.org/W2140513457', 'https://openalex.org/W2144977863', 'https://openalex.org/W2145155871', 'https://openalex.org/W2158971210', 'https://openalex.org/W2162093324', 'https://openalex.org/W2162438863', 'https://openalex.org/W2165909301', 'https://openalex.org/W2167118090', 'https://openalex.org/W2331221462', 'https://openalex.org/W2408879707', 'https://openalex.org/W2534063678', 'https://openalex.org/W2585416850', 'https://openalex.org/W4242138200', 'https://openalex.org/W4253127638', 'https://openalex.org/W62038912', 'https://openalex.org/W72074902', 'https://openalex.org/W85829354'], 'related_works': ['https://openalex.org/W4235617113', 'https://openalex.org/W4200528065', 'https://openalex.org/W3151757475', 'https://openalex.org/W2336192459', 'https://openalex.org/W2145470144', 'https://openalex.org/W2074141861', 'https://openalex.org/W2043322963', 'https://openalex.org/W1968568016', 'https://openalex.org/W1483077634', 'https://openalex.org/W1043690502'], 'abstract_inverted_index': {'Epigenetic': [0], 'regulation': [1], 'of': [2, 8, 30, 33, 73, 94], 'gene': [3], 'transcription': [4], 'by': [5], 'small-molecule': [6], 'inhibitors': [7], 'histone': [9], 'deacetylases': [10], '(HDACs)': [11], 'is': [12, 21], 'a': [13], 'novel': [14], 'cancer': [15], 'therapy.': [16], 'Vorinostat': [17, 38], '(suberoylanilide': [18], 'hydroxamic': [19], 'acid)': [20], 'the': [22, 28, 109], 'first': [23], 'FDA-approved': [24], 'HDAC': [25], 'inhibitor': [26], 'for': [27], 'treatment': [29], 'cutaneous': [31, 34], 'manifestations': [32], 'T-cell': [35], 'lymphoma': [36], '(CTCL).': [37], 'was': [39, 64, 114], 'active': [40], 'against': [41], 'solid': [42], 'tumors': [43], 'and': [44, 49, 66, 87, 106, 108], 'hematologic': [45], 'malignancies': [46], 'as': [47], 'intravenous': [48], 'oral': [50], 'preparations': [51], 'in': [52, 77, 99], 'Phase': [53, 58], 'I': [54], 'development.': [55], 'In': [56], 'two': [57], 'II': [59], 'trials,': [60], 'vorinostat': [61], '400': [62], 'mg/day': [63], 'safe': [65], 'effective': [67], 'with': [68, 81], 'an': [69], 'overall': [70], 'response': [71], 'rate': [72], '24': [74], '–': [75], '30%': [76], 'refractory': [78], 'advanced': [79], 'patients': [80], 'CTCL': [82], 'including': [83], 'large': [84], 'cell': [85], 'transformation': [86], 'Sézary': [88], 'syndrome.': [89], 'The': [90], 'common': [91, 111], 'side': [92], 'effects': [93], 'vorinostat,': [95], 'which': [96], 'are': [97], 'similar': [98], 'all': [100], 'studies,': [101], 'include': [102], 'gastrointestinal': [103], 'symptoms,': [104], 'fatigue': [105], 'thrombocytopenia': [107], 'most': [110], 'serious': [112], 'event': [113], 'thrombosis.': [115]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1968568016', 'counts_by_year': [{'year': 2024, 'cited_by_count': 9}, {'year': 2023, 'cited_by_count': 13}, {'year': 2022, 'cited_by_count': 10}, {'year': 2021, 'cited_by_count': 18}, {'year': 2020, 'cited_by_count': 20}, {'year': 2019, 'cited_by_count': 16}, {'year': 2018, 'cited_by_count': 15}, {'year': 2017, 'cited_by_count': 13}, {'year': 2016, 'cited_by_count': 12}, {'year': 2015, 'cited_by_count': 16}, {'year': 2014, 'cited_by_count': 14}, {'year': 2013, 'cited_by_count': 28}, {'year': 2012, 'cited_by_count': 25}], 'updated_date': '2024-12-18T05:25:22.797405', 'created_date': '2016-06-24'}